Monika A. Davare

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors”.

NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors

Communications Biology(2020)10.1038/s42003-020-01508-w

N/A

2.2DataRank · unranked

63 citations

Nicolle E. Hofmann, Bryan D. Smith, Igor Odintsov, Morana Vojnic, Irina Linkov +10 more

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3321

N/A

1.9DataRank · unranked

48 citations

Adam J. Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa +17 more

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1030

N/A

0.846DataRank · unranked

280 citations

Alan Mackay, Britta Ismer, Jessica C. Pickles, Ruth G. Tatevossian, Scott Newman +95 more

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2278

N/A

0.724DataRank · unranked

124 citations

Melissa L. Johnson, Sarah Clifford, Romel Somwar, Jennifer Kherani, Jieun Son +23 more

MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1 -Fusion-Positive Lung Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0025

N/A

0.373DataRank · unranked

11 citations

Igor Odintsov, Adam J. Schoenfeld, Evan Siau, Marissa S. Mattar, Elisa de Stanchina +7 more

Discovery and Validation of a Compound to Target Ewing’s Sarcoma

Pharmaceutics(2021)10.3390/pharmaceutics13101553

N/A

0DataRank · unranked

5 citations

Fahad Y. Sabei, W. Vogel, Mohamad Nazari, Katelyn S. Nicholson, Philip R. Gafken +5 more

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.27.521482

N/A

0DataRank · unranked

1 citations

Kevin D. Nusser, Kristen L. Jones, Pushkar Shinde, Catherine Z. Beach, Clare Keddy +5 more

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

Nature Cancer(2023)10.1038/s43018-023-00630-y

N/A

0DataRank · unranked

38 citations

Igor Odintsov, Keiji Ishida, Allan J.W. Lui, Masanori Kato, Tatsuya Suzuki +28 more

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

EMBO Molecular Medicine(2023)10.15252/emmm.202217367

N/A

0DataRank · unranked

14 citations

Kevin D. Nusser, Kristen L. Jones, Pushkar Shinde, Clare Keddy, Catherine Z. Beach +5 more

TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers

npj Precision Oncology(2024)10.1038/s41698-024-00663-1

N/A

0DataRank · unranked

9 citations

Matteo Repetto, Clare Keddy, Katelyn S. Nicholson, Kristen L. Jones, Kevin D. Nusser +5 more

TKI Type Switching Overcomes ROS1 L2086F in ROS1 Fusion-Positive Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.16.575901

N/A

0DataRank · unranked

3 citations

Matteo Repetto, Clare Keddy, Katelyn S. Nicholson, Kristen L. Jones, Kevin D. Nusser +5 more

Clinical and preclinical insights into a novel MDM2::PDGFRA fusion in recurrent glioblastoma

npj Precision Oncology(2025)10.1038/s41698-025-01076-4

N/A

0DataRank · unranked

2 citations

Christopher A. Febres‐Aldana, Juan Luis Gomez Marti, Saeed Asiry, Tamika Wong, John A. Boockvar +5 more

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

Disease Models & Mechanisms(2020)10.1242/dmm.047779

N/A

0DataRank · unranked

12 citations

Igor Odintsov, Roger S. Smith, Kota Ishizawa, Allan J. W. Liu, Lukas Delasos +17 more

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms

Blood(2020)10.1182/blood.2019003691

N/A

0DataRank · unranked

40 citations

Kristin Qian, William H. Bisson, Kevin Watanabe‐Smith, Ariane Huang, Daniel Bottomly +7 more

Subtle sequence variations alter tripartite complex kinetics and G-quadruplex dynamics in RNA aptamer Broccoli

Chemical Communications(2020)10.1039/c9cc09375c

N/A

0DataRank · unranked

7 citations

Monika A. Davare, Ujwal Shinde, Jonathan C. Savage

A targeted combinatorial therapy for Ewing's sarcoma

Nanomedicine Nanotechnology Biology and Medicine(2021)10.1016/j.nano.2021.102446

N/A

0DataRank · unranked

10 citations

Olena Taratula, Hassan A. Albarqi, Adel Al Fatease, Abraham S. Moses, Ananiya A. Demessie +8 more